Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
0.7600
+0.0232 (3.15%)
At close: Feb 27, 2026, 4:00 PM EST
0.7550
-0.0050 (-0.66%)
After-hours: Feb 27, 2026, 7:47 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
Genetic Diagnostic Testing | 893.99K | 895.48K | 529.88K | 577.35K | 493.57K | |
Genetic Diagnostic Testing Growth | -0.17% | 69.00% | -8.22% | 16.98% | 75.40% | |
| 893.99K | 895.48K | 529.88K | 577.35K | 493.57K | |
| -0.17% | 69.00% | -8.22% | 16.98% | 75.40% | |
Source: S&P Global Market Intelligence.
